Skip to content
57

nasal spray

Worth a look

Shows a $9.7M/yr market, but a failed launch gate (market size, growth, or returns) keeps it on the watch list.

Market size 100Growth 13Conversion 100Competition 55Returns 100Price range 59Avg price 58Brand share 26Review moat 23Quality gap 24

Market size

Incredible$9.7M

$9.7M/yr · 3.7M searches

Conversion

Incredible20.5%

search→purchase rate — share of searches ending in a sale

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Price range

Good$3.16–$32.38

cheapest to priciest tracked listing — scored on the share inside $15–$100

Avg price

Good$12.90

avg listing price — sweet spot $15–$100

Competition

Good52%

top-5 click share — leaders hold, buyers still browse

Brand share

Okay89%

top-5 brand share — brands hold most of the demand

Quality gap

Bad4.6★

avg incumbent rating — lower means beatable quality

Review moat

Bad7,753.9

avg incumbent reviews — the moat a new listing must climb

Growth

Bad-23.6%

90-day search growth — must beat 0% to launch

Competition

The top 5 products take 52% of clicks — established leaders, but buyers still shop beyond them.

Brands

11 falling

Sellers

146

Top-5 brand share

89%

Open market

8%

  • Afrin41%
  • Amazon Basic Care33%
  • Vicks7%
  • Arm & Hammer4%
  • Flonase3%
  • Mucinex3%
  • Open — no brand owns it (5 brands, 8%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%4%$388K8%$776K12%$1.2M16%$1.6M1001K10K100K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 29 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — -23.6% search growth over the last 90 days.
90K70KSpike '25SepDecMarJunAugNovMarMay

Peak months: Jan · busiest ÷ quietest = 2.0×